Drug interactions between Cartia XT and Grifulvin V
Results for the following 2 drugs: |
|
|---|---|
| Cartia XT (diltiazem) | |
| Grifulvin V (griseofulvin) | |
Interactions between your selected drugs
diltiazem ⇔ griseofulvin
Applies to: Cartia XT (diltiazem) and Grifulvin V (griseofulvin)
GENERALLY AVOID: Coadministration with inducers of CYP450 3A4 may significantly decrease the plasma concentrations of diltiazem, which is primarily metabolized by the isoenzyme. In one study, coadministration with the inducer efavirenz (600 mg daily for 14 days) decreased the peak plasma concentration (Cmax), trough plasma concentration (Cmin) and systemic exposure (AUC) of diltiazem (240 mg daily for 21 days) by a mean of 60%, 63% and 69%, respectively, in 13 subjects. Rifampin, another CYP450 3A4 inducer, has been reported to lower diltiazem plasma concentrations to undetectable levels.
MANAGEMENT: Use of diltiazem with rifampin or any known CYP450 3A4 inducer should be avoided when possible, and alternative therapy considered. Diltiazem dose adjustment should be guided by clinical response if concomitant use with a CYP450 3A4 inducer is necessary.
See also...
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2009 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
